Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn’s Patients.

Jan 13, 2021 | Recent Research, Treatment Strategies

Related Articles

Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn’s Patients.

Dig Dis Sci. 2021 Jan 12;:

Authors: Rakowsky ST, Feuerstein JD

PMID: 33433791 [PubMed – as supplied by publisher]

Full Text Link: https://libkey.io/33433791

Email Newsletter

Recent News

Cigarette smoking increases colorectal neoplasia risk in IBD
January 14, 2021
Genetic biomarker linking Takayasu arteritis, IBD may guide targeted therapies
January 6, 2021
VIDEO: ‘Exciting’ therapies in the pipeline for IBD
December 29, 2020
VIDEO: Benefit of COVID-19 vaccine outweighs risks in IBD patients
December 29, 2020
More data needed on minority populations to enhance IBD risk scores
December 28, 2020
Emerging therapies in IBD
December 22, 2020
VIDEO: IBD therapies not linked with adverse pregnancy outcomes
December 19, 2020
VIDEO: COVID vaccine among hot topics from AIBD 2020
December 18, 2020
VIDEO: FMT safe for C. diff, J- pouches in IBD
December 18, 2020
VIDEO: Virtual AIBD provides new opportunities
December 17, 2020